Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-alcoholic fatty liver disease and risk of type 2 diabetes
Susanna Lallukka, Hannele Yki‐Järvinen
Best Practice & Research Clinical Endocrinology & Metabolism (2016) Vol. 30, Iss. 3, pp. 385-395
Closed Access | Times Cited: 126

Showing 1-25 of 126 citing articles:

Association between insulin resistance and the development of cardiovascular disease
Valeska Ormazábal, Soumyalekshmi Nair, Omar Elfeky, et al.
Cardiovascular Diabetology (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 1639
Metabolically Healthy Obesity
Matthias Blüher
Endocrine Reviews (2020) Vol. 41, Iss. 3
Open Access | Times Cited: 718
Metabolomics and Metabolic Diseases: Where Do We Stand?
Christopher B. Newgard
Cell Metabolism (2016) Vol. 25, Iss. 1, pp. 43-56
Open Access | Times Cited: 623
Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases
Varman T. Samuel, Gerald I. Shulman
Cell Metabolism (2017) Vol. 27, Iss. 1, pp. 22-41
Open Access | Times Cited: 605
Determinants of fibrosis progression and regression in NASH
Detlef Schuppan, Rambabu Surabattula, Xiaoyu Wang
Journal of Hepatology (2017) Vol. 68, Iss. 2, pp. 238-250
Closed Access | Times Cited: 419
Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors
Sven Francque, Gyöngyi Szabó, Manal F. Abdelmalek, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 18, Iss. 1, pp. 24-39
Closed Access | Times Cited: 241
The Metabolic Syndrome in Men study: a resource for studies of metabolic and cardiovascular diseases
Markku Laakso, Johanna Kuusisto, Alena Stančáková, et al.
Journal of Lipid Research (2017) Vol. 58, Iss. 3, pp. 481-493
Open Access | Times Cited: 190
Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD)
Ali Saeed, Robin P. F. Dullaart, T.C.M.A. Schreuder, et al.
Nutrients (2017) Vol. 10, Iss. 1, pp. 29-29
Open Access | Times Cited: 185
Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies
Carmelo Luci, Manon Bourinet, Pierre Leclère, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 146
Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia
Marisa R. Morrow, Battsetseg Batchuluun, Jianhan Wu, et al.
Cell Metabolism (2022) Vol. 34, Iss. 6, pp. 919-936.e8
Open Access | Times Cited: 111
NAFLD and Diabetes: Two Sides of the Same Coin? Rationale for Gene-Based Personalized NAFLD Treatment
Mingfeng Xia, Hua Bian, Xin Gao
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 118
Reproductive Endocrinology of Nonalcoholic Fatty Liver Disease
Mathis Grossmann, Margaret E. Wierman, Peter Angus, et al.
Endocrine Reviews (2018) Vol. 40, Iss. 2, pp. 417-446
Open Access | Times Cited: 97
Insulin resistance and reduced metabolic flexibility: cause or consequence of NAFLD?
Amalia Gastaldelli
Clinical Science (2017) Vol. 131, Iss. 22, pp. 2701-2704
Closed Access | Times Cited: 90
Potential Nexus of Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Insulin Resistance Between Hepatic and Peripheral Tissues
Wan Mu, Xuefang Cheng, Ying Liu, et al.
Frontiers in Pharmacology (2019) Vol. 9
Open Access | Times Cited: 90
Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage
Mario Masarone, Valerio Rosato, Andrea Aglitti, et al.
PLoS ONE (2017) Vol. 12, Iss. 6, pp. e0178473-e0178473
Open Access | Times Cited: 89
Metabolic-Associated Fatty Liver Disease (MAFLD), Diabetes, and Cardiovascular Disease: Associations with Fructose Metabolism and Gut Microbiota
Karolina Drożdż, Katarzyna Nabrdalik, Weronika Hajzler, et al.
Nutrients (2021) Vol. 14, Iss. 1, pp. 103-103
Open Access | Times Cited: 72
Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus—The Chicken or the Egg Dilemma
Marcin Kosmalski, Agnieszka Śliwińska, Józef Drzewoski
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1097-1097
Open Access | Times Cited: 25
The hepatic-targeted, resveratrol loaded nanoparticles for relief of high fat diet-induced nonalcoholic fatty liver disease
Wendi Teng, Liyun Zhao, Songtao Yang, et al.
Journal of Controlled Release (2019) Vol. 307, pp. 139-149
Closed Access | Times Cited: 70
Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
Daud Akhtar, Umair Iqbal, Luis Miguel Vazquez‐Montesino, et al.
Journal of Clinical and Translational Hepatology (2019) Vol. 7, Iss. X, pp. 1-9
Open Access | Times Cited: 67
The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases
Kamila Wójcik, Ewa Koślińska-Berkan, Anna Piekarska
Clinical and Experimental Hepatology (2018) Vol. 4, Iss. 1, pp. 1-6
Open Access | Times Cited: 66
Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease
Sara Jarmakiewicz-Czaja, Aneta Sokal, Piotr Pardak, et al.
Canadian Journal of Gastroenterology and Hepatology (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 29
Systems Analysis of the Liver Transcriptome in Adult Male Zebrafish Exposed to the Plasticizer (2-Ethylhexyl) Phthalate (DEHP)
Matthew Huff, Willian A. da Silveira, Oliana Carnevali, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 57
Pyruvate dehydrogenase kinase 4 mediates lipogenesis and contributes to the pathogenesis of nonalcoholic steatohepatitis
Ming Zhang, Yujie Zhao, Zhen Li, et al.
Biochemical and Biophysical Research Communications (2017) Vol. 495, Iss. 1, pp. 582-586
Closed Access | Times Cited: 53
The efficacy of vitamin E in reducing non-alcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression
Mohamed Abdel-Maboud, Amr Menshawy, Esraa Menshawy, et al.
Therapeutic Advances in Gastroenterology (2020) Vol. 13
Open Access | Times Cited: 49
Relationship Between Intermittent Hypoxia and Type 2 Diabetes in Sleep Apnea Syndrome
Hiroyo Ota, Yukio Fujita, Motoo Yamauchi, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 19, pp. 4756-4756
Open Access | Times Cited: 48
Page 1 - Next Page

Scroll to top